ADSS

Aaron Brown Joins iSAM Securities to Drive Growth in MENA Region

Retrieved on: 
Lundi, février 26, 2024

Aaron Brown joins iSAM Securities in a strategic move to expand into the Middle East.

Key Points: 
  • Aaron Brown joins iSAM Securities in a strategic move to expand into the Middle East.
  • View the full release here: https://www.businesswire.com/news/home/20240223103047/en/
    Aaron Brown Joins iSAM Securities to Drive Growth in MENA Region (Photo: Business Wire)
    Joining iSAM Securities after his departure from IXO Prime, where he was Head of Institutional Sales MENA, Brown brings a range of expertise to the group.
  • iSAM Securities, recognized for its award-winning multi-asset liquidity, cutting-edge technology, and robust risk management services, is poised to offer these capabilities to institutional clients in the MENA region.
  • Samuel Johnson, Managing Director, iSAM Securities said, “We are delighted to welcome Aaron Brown to the team and work with him to spearhead our growth in the region.

YOFC Unveils Cutting-edge Innovations at 2024 MWC Barcelona

Retrieved on: 
Jeudi, février 29, 2024

BARCELONA, Spain, Feb. 29, 2024 /PRNewswire/ -- Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), a leader in the global optical fibre and cable market, showcased a suite of advanced products and solutions at the 2024 Mobile World Congress Barcelona (MWC Barcelona).

Key Points: 
  • BARCELONA, Spain, Feb. 29, 2024 /PRNewswire/ -- Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), a leader in the global optical fibre and cable market, showcased a suite of advanced products and solutions at the 2024 Mobile World Congress Barcelona (MWC Barcelona).
  • During the exhibition, YOFC showcased its latest optical fibre innovations:
    FarBand® Ultra G.654.E Fibre: Known for its exceptionally low attenuation, enhancing long-distance communication capabilities.
  • Progressing beyond the traditional III-V technology, YOFC introduced its next-generation 400G/800G optical module solution, leveraging silicon photonics technology.
  • Since 2014, YOFC has embarked on an ambitious mission to bring optical fibre connectivity to the most remote corners of the planet.

YOFC Unveils Cutting-edge Innovations at 2024 MWC Barcelona

Retrieved on: 
Jeudi, février 29, 2024

BARCELONA, Spain, Feb. 29, 2024 /PRNewswire/ -- Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), a leader in the global optical fibre and cable market, showcased a suite of advanced products and solutions at the 2024 Mobile World Congress Barcelona (MWC Barcelona).

Key Points: 
  • BARCELONA, Spain, Feb. 29, 2024 /PRNewswire/ -- Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC), a leader in the global optical fibre and cable market, showcased a suite of advanced products and solutions at the 2024 Mobile World Congress Barcelona (MWC Barcelona).
  • During the exhibition, YOFC showcased its latest optical fibre innovations:
    FarBand® Ultra G.654.E Fibre: Known for its exceptionally low attenuation, enhancing long-distance communication capabilities.
  • Progressing beyond the traditional III-V technology, YOFC introduced its next-generation 400G/800G optical module solution, leveraging silicon photonics technology.
  • Since 2014, YOFC has embarked on an ambitious mission to bring optical fibre connectivity to the most remote corners of the planet.

YOFC's Debut on Connected Britain 2023

Retrieved on: 
Mardi, septembre 26, 2023

LONDON, Sept. 26, 2023 /PRNewswire/ -- From 20 to 21 September, Connected Britain 2023, the Britain's premier digital economy event, kicked off in London, Britain.

Key Points: 
  • LONDON, Sept. 26, 2023 /PRNewswire/ -- From 20 to 21 September, Connected Britain 2023, the Britain's premier digital economy event, kicked off in London, Britain.
  • Yangtze Optical Fibre and Cable Joint Stock Limited Company, made a spectacular appearance at the event debuting new optical fibre and optical cable products, and data centre and F.ODN pre-connection solutions.
  • YOFC's F.ODN pre-connection solutions have been successfully applied in projects in Argentina and France, and gained widespread recognition among local clients.
  • Through the Connected Britain event, YOFC sought to deepen exchanges and cooperation with its global peers in the industry, so as to make its own contributions to the building of information and telecommunication infrastructure and network connections in Britain and other parts of the world.

Octo is Awarded Contract to Replace Auction System at the Federal Communications Commission

Retrieved on: 
Mardi, juin 20, 2023

Octo, an IBM company, announced today it has been awarded a 40-month, $8.9 million task order to support the Federal Communications Commission (FCC) Auction Application System (AAS) program under the Application Development Support Services (ADSS) IDIQ.

Key Points: 
  • Octo, an IBM company, announced today it has been awarded a 40-month, $8.9 million task order to support the Federal Communications Commission (FCC) Auction Application System (AAS) program under the Application Development Support Services (ADSS) IDIQ.
  • We are excited to return to the Commission and work with Nüvitek, Emprata, and DefyneIT,” said Brian Funk, Vice President of Technology Solutions at Octo.
  • Together, our teams will help the OEA Auctions Division meet their mission to operate auctions in the most efficient manner possible.”
    AAS is an IT system development project to replace the legacy auction management system.
  • We are excited to be working with them as they replace their current auction system.”

Orchard Therapeutics Announces Proposed ADS Ratio Change

Retrieved on: 
Vendredi, février 10, 2023

BOSTON and LONDON, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to its ordinary shares (the "ADS Ratio"), nominal value £0.10 per share, from the current ADS Ratio of one (1) ADS to one (1) ordinary share to a new ADS Ratio of one (1) ADS to ten (10) ordinary shares (the “ADS Ratio Change”).

Key Points: 
  • BOSTON and LONDON, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to its ordinary shares (the "ADS Ratio"), nominal value £0.10 per share, from the current ADS Ratio of one (1) ADS to one (1) ordinary share to a new ADS Ratio of one (1) ADS to ten (10) ordinary shares (the “ADS Ratio Change”).
  • For the company's ADS holders, the change in the ADS Ratio will have the same effect as a one-for-ten reverse ADS split and is intended to enable the company to regain compliance with the Nasdaq minimum bid price requirement.
  • The ADS Ratio Change will have no impact on Orchard’s underlying ordinary shares, and no ordinary shares will be issued or cancelled in connection with the ADS Ratio Change.
  • As a result of the change in the ADS Ratio, Orchard’s ADS trading price is expected to increase proportionally, although the company can give no assurance that the ADS trading price after the ADS Ratio Change will be equal to or greater than ten (10) times the ADS trading price before the change.

Hesai Group Announces Pricing of Initial Public Offering

Retrieved on: 
Jeudi, février 9, 2023

SHANGHAI, China, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai,” “Hesai Technology” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (LiDAR) solutions, today announced the pricing of its initial public offering of 10.0 million American Depositary Shares (“ADSs”), at US$19.00 per ADS, for a total offering size of US$190.0 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs.

Key Points: 
  • SHANGHAI, China, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai,” “Hesai Technology” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (LiDAR) solutions, today announced the pricing of its initial public offering of 10.0 million American Depositary Shares (“ADSs”), at US$19.00 per ADS, for a total offering size of US$190.0 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs.
  • In addition, the Company has granted the underwriters an option, exercisable within 30 days from the date of the final prospectus, to purchase up to an aggregate of 1.5 million additional ADSs at the initial public offering price.
  • Goldman Sachs (Asia) L.L.C., Morgan Stanley Asia Limited and Credit Suisse Securities (USA) LLC are acting as joint bookrunners for the offering.
  • A copy of the final prospectus relating to the offering may be obtained, when available, by contacting the following underwriters:

Purple Biotech Reports Fourth Quarter and Full-Year 2022 Financial Results

Retrieved on: 
Mercredi, février 8, 2023

REHOVOT, Israel, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced financial results for the year and the three months ended December 31, 2022.

Key Points: 
  • “We are reporting our 2022 financial results which are in line with our plans,” said Gil Efron, Chief Executive Officer of Purple Biotech.
  • The acquisition provides Purple Biotech with a technology platform for tri-specific antibody compounds and offers the potential to further expand to additional targets.
  • Also after the close of fiscal 2022, Purple Biotech announced on January 3, 2023, a research collaboration with Mor Research Applications, the technology transfer subsidiary of Clalit Healthcare Services.
  • As of December 31, 2022, Purple Biotech had cash and cash equivalents, short- and long-term deposits of $31.7 million, compared to $47.4 million on December 31, 2021.

GAOTU TECHEDU SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. - GOTU, G

Retrieved on: 
Mercredi, février 8, 2023

NEW ORLEANS, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 28, 2023 to file lead plaintiff applications in a securities class action lawsuit against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (NYSE: GOTU, GSX), if they purchased the Company’s American depository shares (“ADSs”) between March 5, 2021 and July 23, 2021, inclusive (the “Class Period”).

Key Points: 
  • NEW ORLEANS, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 28, 2023 to file lead plaintiff applications in a securities class action lawsuit against Gaotu Techedu Inc. f/k/a GSX Techedu Inc. (NYSE: GOTU, GSX), if they purchased the Company’s American depository shares (“ADSs”) between March 5, 2021 and July 23, 2021, inclusive (the “Class Period”).
  • This action is pending in the United States District Court for the Eastern District of New York.
  • If you purchased ADSs of Gaotu and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-gotu/ to learn more.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 28, 2023.

Cellectis Announces Closing of Global Offering and Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Mercredi, février 8, 2023

The Additional ADSs will be listed on the Nasdaq Global Market under the symbol “CLLS”, and the Company’s Additional Ordinary Shares will be listed on Euronext Growth in Paris under the symbol “ALCLS”.

Key Points: 
  • The Additional ADSs will be listed on the Nasdaq Global Market under the symbol “CLLS”, and the Company’s Additional Ordinary Shares will be listed on Euronext Growth in Paris under the symbol “ALCLS”.
  • The closing of the Option is expected to occur on February 8, 2023, subject to customary closing conditions.
  • Jefferies LLC and Barclays Capital Inc. acted as joint book-running managers for the Global Offering.
  • The partial exercise of the Option is part of stabilization activities carried out since the announcement of Cellectis' Global Offering.